ArticleBioengineered2022

miR-877-3p inhibits tumor growth and angiogenesis of osteosarcoma through fibroblast growth factor 2 signaling.

Mingji Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.